The most differentially over-represented signaling pathways in LUAD patients with the elevated MND1 expression included the p53 signaling pathway, pancreatic cancer, small cell lung cancer, bladder cancer, melanoma, and colorectal cancer (Table 5). The gene discussed is TP53; the disease is small cell lung carcinoma.